16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      β Cell Hypoxia-Inducible Factor-1 α Is Required for the Prevention of Type 1 Diabetes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          SUMMARY

          The development of autoimmune disease type 1 diabetes (T1D) is determined by both genetic background and environmental factors. Environmental triggers include RNA viruses, particularly coxsackie-virus (CV), but how they induceT1D is not understood. Here, we demonstrate that deletion of the transcription factor hypoxia-inducible factor-1α (HIF-1α) from β cells increases the susceptibility of non-obese diabetic (NOD) mice to environmentally triggered T1D from coxsackieviruses and the β cell toxin streptozotocin. Similarly, knockdown of HIF-1α in human islets leads to a poorer response to coxsackievirus infection. Studies in coxsackievirus-infected islets demonstrate that lack of HIF-1α leads to impaired viral clearance, increased viral load, inflammation, pancreatitis, and loss of β cell mass. These findings show an important role for β cells and, specifically, lack of β cell HIF-1α in the development of T1D. These data suggest new strategies for the prevention of T1D.

          Graphical Abstract

          In Brief

          Lalwani et al. describe a role for β cell hypoxia-inducible factor-1α (HIF1a) in determining whether β cell injury is followed by resolution and normal function or ongoing injury, autoimmunity, and type 1 diabetes.

          Related collections

          Most cited references66

          • Record: found
          • Abstract: found
          • Article: not found

          Fibrosis and adipose tissue dysfunction.

          Fibrosis is increasingly appreciated as a major player in adipose tissue dysfunction. In rapidly expanding adipose tissue, pervasive hypoxia leads to an induction of HIF1α that in turn leads to a potent profibrotic transcriptional program. The pathophysiological impact of adipose tissue fibrosis is likely to play an equally important role on systemic metabolic alterations as fibrotic conditions play in the liver, heart, and kidney. Here, we discuss recent advances in our understanding of the genesis, modulation, and systemic impact of excessive extracellular matrix (ECM) accumulation in adipose tissue of both rodents and humans and the ensuing impact on metabolic dysfunction. Copyright © 2013 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Epidemiology of type 1 diabetes.

            This article describes the epidemiology of type 1 diabetes mellitus (T1D) around the world and across the lifespan. Epidemiologic patterns of T1D by demographic, geographic, biologic, cultural, and other factors in populations are presented to gain insight about the causes, natural history, risks, and complications of T1D. Data from large epidemiologic studies worldwide indicate that the incidence of T1D has been increasing by 2% to 5% worldwide and that the prevalence of T1D is approximately 1 in 300 in the United States by 18 years of age. Research on risk factors for T1D is an active area of research to identify genetic and environmental triggers that could potentially be targeted for intervention. Although significant advances have been made in the clinical care of T1D with resultant improvements in quality of life and clinical outcomes, much more needs to be done to improve care of, and ultimately find a cure for, T1D. Epidemiologic studies have an important ongoing role to investigate the complex causes, clinical care, prevention, and cure of T1D. Copyright 2010 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue.

              Adipose tissue can undergo rapid expansion during times of excess caloric intake. Like a rapidly expanding tumor mass, obese adipose tissue becomes hypoxic due to the inability of the vasculature to keep pace with tissue growth. Consequently, during the early stages of obesity, hypoxic conditions cause an increase in the level of hypoxia-inducible factor 1alpha (HIF1alpha) expression. Using a transgenic model of overexpression of a constitutively active form of HIF1alpha, we determined that HIF1alpha fails to induce the expected proangiogenic response. In contrast, we observed that HIF1alpha initiates adipose tissue fibrosis, with an associated increase in local inflammation. "Trichrome- and picrosirius red-positive streaks," enriched in fibrillar collagens, are a hallmark of adipose tissue suffering from the early stages of hypoxia-induced fibrosis. Lysyl oxidase (LOX) is a transcriptional target of HIF1alpha and acts by cross-linking collagen I and III to form the fibrillar collagen fibers. Inhibition of LOX activity by beta-aminoproprionitrile treatment results in a significant improvement in several metabolic parameters and further reduces local adipose tissue inflammation. Collectively, our observations are consistent with a model in which adipose tissue hypoxia serves as an early upstream initiator for adipose tissue dysfunction by inducing a local state of fibrosis.
                Bookmark

                Author and article information

                Journal
                101573691
                39703
                Cell Rep
                Cell Rep
                Cell reports
                2211-1247
                3 July 2019
                21 May 2019
                21 April 2020
                : 27
                : 8
                : 2370-2384.e6
                Affiliations
                [1 ]Center for Diabetes, Obesity, and Endocrinology (CDOE), The Westmead Institute for Medical Research (WIMR), The University of Sydney, Sydney, NSW, Australia
                [2 ]Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia
                [3 ]Mucosal Autoimmunity, Garvan Institute of Medical Research, Sydney, NSW, Australia
                [4 ]National Pancreas Transplant Unit (NPTU), Westmead Hospital, Sydney, NSW, Australia
                [5 ]Laboratory of Metabolism, National Cancer Institute, Bethesda, MD, USA
                [6 ]Islet Biology, Garvan Institute of Medical Research, Sydney, NSW, Australia
                [7 ]The Children’s Hospital at Westmead, Sydney, NSW, Australia
                [8 ]School of Women’s and Children’s Health, University of New South Wales, Kensington, NSW, Australia
                [9 ]School of Medical Sciences, University of New South Wales, Kensington, NSW, Australia
                [10 ]St Vincent’s Clinical School, University of New South Wales, Kensington, NSW, Australia
                [11 ]Department of Diabetes and Endocrinology, Westmead Hospital, Sydney, NSW, Australia
                [12 ]These authors contributed equally
                [13 ]Senior author
                [14 ]Lead Contact
                Author notes

                AUTHOR CONTRIBUTIONS

                A.L. designed and performed studies and discussed and drafted the manuscript. J.W. (plaque assays), R.A.S. (islet isolations), D.L. (flow cytometry), and J.C. (immunohistochemistry staining) provided experimental assistance. W.J.H. and P.J.O. provided assistance with the preparation of human islets. F.J.G. provided the original βHIF-1α C57BL/6 mice. D.R.L. performed part of the real-time PCRs for Figure 6C. M.E.C. provided CVB1. C.K. provided CVB4. W.J.H., D.R.L., and M.E.C. provided helpful comments for the manuscript. M.M.S., C.K., and J.E.G. conceived the majority of the studies and discussed, reviewed, and edited the manuscript.

                Article
                NIHMS1037076
                10.1016/j.celrep.2019.04.086
                6661122
                31116982
                34a8339a-65b6-40ca-88f7-0b0bf6d8057d

                This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                Categories
                Article

                Cell biology
                Cell biology

                Comments

                Comment on this article